Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Commission
Pharma
After FDA rejection, Regeneron scores EU nod for Lynozyfic
Regeneron is off and running with its launch of linvoseltamab in Europe. In the U.S., the company is awaiting an FDA decision after a prior rejection.
Eric Sagonowsky
Apr 28, 2025 10:12am
Sanofi, Novartis CEOs blast EU austerity amid US tariff threat
Apr 23, 2025 12:25am
Pharmas demand changes to stay in EU amid looming Trump tariffs
Apr 16, 2025 10:41am
Eisai and Biogen's Alzheimer's med Leqembi approved in Europe
Apr 16, 2025 7:52am
CHMP again backs Leqembi amid flurry of approval recommendations
Feb 28, 2025 10:30am
European officials approve Novo Holdings' planned Catalent buy
Dec 6, 2024 2:48pm